{"entity":{"type":"insider","cik":"0001598480","url":"/insider/0001598480","json_url":"/insider/0001598480.json","name":"Weissman James B","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":35,"n_filings":29,"first":"2014-02-20","last":"2021-07-08","span_basis":"filed_date"},"name_variants":[{"name":"Weissman James B","source":"filing","n_filings":29,"first_seen":"2014-02-20","last_seen":"2021-07-08"}],"transactions":[{"id":4692823,"accession":"0001399529-21-000132","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001399529-21-000132","line_url":"/filing/0001399529-21-000132#line-2","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (Chief Operating Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":39.09,"price_display":"39.09","price_state":"stated","total_value":1172700.0,"total_display":"1,172,700.00","total_whole":"1,172,700","shares_owned_after":16000.0,"shares_owned_after_display":"16,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-06","filed_date":"2021-07-08","scope":"insider"},{"id":4862018,"accession":"0001399529-21-000078","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001399529-21-000078","line_url":"/filing/0001399529-21-000078#line-1","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (Chief Operating Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4904.0,"shares_display":"4,904","price_per_share":29.99,"price_display":"29.99","price_state":"stated","total_value":147070.96,"total_display":"147,070.96","total_whole":"147,071","shares_owned_after":16000.0,"shares_owned_after_display":"16,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-16","filed_date":"2021-04-20","scope":"insider"},{"id":5412662,"accession":"0001399529-21-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001399529-21-000031","line_url":"/filing/0001399529-21-000031#line-1","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (Chief Operating Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7156.0,"shares_display":"7,156","price_per_share":26.99,"price_display":"26.99","price_state":"stated","total_value":193140.44,"total_display":"193,140.44","total_whole":"193,140","shares_owned_after":20904.0,"shares_owned_after_display":"20,904","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-05","filed_date":"2021-02-08","scope":"insider"},{"id":4692797,"accession":"0001399529-21-000021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001399529-21-000021","line_url":"/filing/0001399529-21-000021#line-1","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (Chief Operating Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5808.0,"shares_display":"5,808","price_per_share":24.082,"price_display":"24.08","price_state":"stated","total_value":139868.256,"total_display":"139,868.26","total_whole":"139,868","shares_owned_after":28060.0,"shares_owned_after_display":"28,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-12","filed_date":"2021-01-13","scope":"insider"},{"id":5313023,"accession":"0001399529-21-000016","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001399529-21-000016","line_url":"/filing/0001399529-21-000016#line-3","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (Chief Operating Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3800.0,"shares_display":"3,800","price_per_share":23.99,"price_display":"23.99","price_state":"stated","total_value":91162.0,"total_display":"91,162.00","total_whole":"91,162","shares_owned_after":33868.0,"shares_owned_after_display":"33,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-12","scope":"insider"},{"id":2570725,"accession":"0001399529-20-000092","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001399529-20-000092","line_url":"/filing/0001399529-20-000092#line-2","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (Chief Operating Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4360.0,"shares_display":"4,360","price_per_share":25.2071,"price_display":"25.21","price_state":"stated","total_value":109902.956,"total_display":"109,902.96","total_whole":"109,903","shares_owned_after":31860.0,"shares_owned_after_display":"31,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-01","filed_date":"2020-12-03","scope":"insider"},{"id":3140822,"accession":"0001399529-20-000082","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001399529-20-000082","line_url":"/filing/0001399529-20-000082#line-2","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (Chief Operating Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4360.0,"shares_display":"4,360","price_per_share":20.948,"price_display":"20.95","price_state":"stated","total_value":91333.28,"total_display":"91,333.28","total_whole":"91,333","shares_owned_after":31860.0,"shares_owned_after_display":"31,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-02","filed_date":"2020-11-03","scope":"insider"},{"id":2490657,"accession":"0001399529-20-000072","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001399529-20-000072","line_url":"/filing/0001399529-20-000072#line-2","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (Chief Operating Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8720.0,"shares_display":"8,720","price_per_share":20.2,"price_display":"20.20","price_state":"stated","total_value":176144.0,"total_display":"176,144.00","total_whole":"176,144","shares_owned_after":21860.0,"shares_owned_after_display":"21,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-15","filed_date":"2020-10-19","scope":"insider"},{"id":3111857,"accession":"0000899243-20-021560","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-021560","line_url":"/filing/0000899243-20-021560","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (EVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4360.0,"shares_display":"4,360","price_per_share":22.472048990825687,"price_display":"22.47","price_state":"stated","total_value":97978.1336,"total_display":"97,978.13","total_whole":"97,978","shares_owned_after":23292.0,"shares_owned_after_display":"23,292","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-05","scope":"insider","n_lines":2},{"id":9204755,"accession":"0000899243-20-024400","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-024400","line_url":"/filing/0000899243-20-024400","is_derivative":false,"issuer_cik":"0001598480","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001598480","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (Chief Operating Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4360.0,"shares_display":"4,360","price_per_share":26.53189997706422,"price_display":"26.53","price_state":"stated","total_value":115679.0839,"total_display":"115,679.08","total_whole":"115,679","shares_owned_after":21860.0,"shares_owned_after_display":"21,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-09-04","scope":"insider","n_lines":2},{"id":2955690,"accession":"0000950123-20-006736","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950123-20-006736","line_url":"/filing/0000950123-20-006736","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (Chief Operating Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4360.0,"shares_display":"4,360","price_per_share":26.53189997706422,"price_display":"26.53","price_state":"stated","total_value":115679.0839,"total_display":"115,679.08","total_whole":"115,679","shares_owned_after":23167.0,"shares_owned_after_display":"23,167","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-01","filed_date":"2020-07-06","scope":"insider","n_lines":2},{"id":2986757,"accession":"0000899243-20-014945","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-014945","line_url":"/filing/0000899243-20-014945#line-2","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (Chief Operating Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4360.0,"shares_display":"4,360","price_per_share":21.0567,"price_display":"21.06","price_state":"stated","total_value":91807.212,"total_display":"91,807.21","total_whole":"91,807","shares_owned_after":21860.0,"shares_owned_after_display":"21,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-01","filed_date":"2020-06-02","scope":"insider"},{"id":2168980,"accession":"0000899243-20-012188","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-012188","line_url":"/filing/0000899243-20-012188#line-2","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (Chief Operating Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4360.0,"shares_display":"4,360","price_per_share":20.2,"price_display":"20.20","price_state":"stated","total_value":88072.0,"total_display":"88,072.00","total_whole":"88,072","shares_owned_after":21860.0,"shares_owned_after_display":"21,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-04","filed_date":"2020-05-06","scope":"insider"},{"id":2132609,"accession":"0000899243-20-010734","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-010734","line_url":"/filing/0000899243-20-010734#line-2","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (Chief Operating Officer & EVP)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4360.0,"shares_display":"4,360","price_per_share":20.2,"price_display":"20.20","price_state":"stated","total_value":88072.0,"total_display":"88,072.00","total_whole":"88,072","shares_owned_after":21860.0,"shares_owned_after_display":"21,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-13","filed_date":"2020-04-14","scope":"insider"},{"id":2418062,"accession":"0000899243-20-006844","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-006844","line_url":"/filing/0000899243-20-006844#line-2","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (EVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4360.0,"shares_display":"4,360","price_per_share":20.6087,"price_display":"20.61","price_state":"stated","total_value":89853.932,"total_display":"89,853.93","total_whole":"89,854","shares_owned_after":21860.0,"shares_owned_after_display":"21,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-03","scope":"insider"},{"id":2281460,"accession":"0000899243-20-002937","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-002937","line_url":"/filing/0000899243-20-002937#line-2","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (EVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4360.0,"shares_display":"4,360","price_per_share":20.2,"price_display":"20.20","price_state":"stated","total_value":88072.0,"total_display":"88,072.00","total_whole":"88,072","shares_owned_after":21860.0,"shares_owned_after_display":"21,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-03","filed_date":"2020-02-04","scope":"insider"},{"id":2506208,"accession":"0000899243-20-000371","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-000371","line_url":"/filing/0000899243-20-000371#line-3","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (EVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4360.0,"shares_display":"4,360","price_per_share":21.8753,"price_display":"21.88","price_state":"stated","total_value":95376.308,"total_display":"95,376.31","total_whole":"95,376","shares_owned_after":21860.0,"shares_owned_after_display":"21,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-03","scope":"insider"},{"id":8308735,"accession":"0000899243-19-028420","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-028420","line_url":"/filing/0000899243-19-028420#line-2","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (EVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":520000.0,"total_display":"520,000.00","total_whole":"520,000","shares_owned_after":14704.0,"shares_owned_after_display":"14,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-02","filed_date":"2019-12-03","scope":"insider"},{"id":7858132,"accession":"0000899243-19-027733","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-027733","line_url":"/filing/0000899243-19-027733#line-4","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (EVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":480000.0,"total_display":"480,000.00","total_whole":"480,000","shares_owned_after":14704.0,"shares_owned_after_display":"14,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-19","filed_date":"2019-11-20","scope":"insider"},{"id":7858127,"accession":"0000899243-19-027733","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-027733","line_url":"/filing/0000899243-19-027733#line-2","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (EVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":440000.0,"total_display":"440,000.00","total_whole":"440,000","shares_owned_after":14704.0,"shares_owned_after_display":"14,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-20","scope":"insider"},{"id":8611593,"accession":"0000899243-19-027441","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-027441","line_url":"/filing/0000899243-19-027441#line-2","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (EVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":400000.0,"total_display":"400,000.00","total_whole":"400,000","shares_owned_after":14704.0,"shares_owned_after_display":"14,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-14","filed_date":"2019-11-15","scope":"insider"},{"id":7992211,"accession":"0000899243-19-026496","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-026496","line_url":"/filing/0000899243-19-026496#line-2","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (EVP & Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":270000.0,"total_display":"270,000.00","total_whole":"270,000","shares_owned_after":14704.0,"shares_owned_after_display":"14,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-31","filed_date":"2019-11-01","scope":"insider"},{"id":8197693,"accession":"0000899243-19-022411","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-022411","line_url":"/filing/0000899243-19-022411#line-1","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14680.0,"shares_display":"14,680","price_per_share":13.0676,"price_display":"13.07","price_state":"stated","total_value":191832.368,"total_display":"191,832.37","total_whole":"191,832","shares_owned_after":9800.0,"shares_owned_after_display":"9,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-23","filed_date":"2019-08-23","scope":"insider"},{"id":8375866,"accession":"0000899243-19-010036","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-010036","line_url":"/filing/0000899243-19-010036#line-2","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":225000.0,"total_display":"225,000.00","total_whole":"225,000","shares_owned_after":24480.0,"shares_owned_after_display":"24,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-02","filed_date":"2019-04-04","scope":"insider"},{"id":6817449,"accession":"0000905148-18-000758","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905148-18-000758","line_url":"/filing/0000905148-18-000758#line-2","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2301.0,"shares_display":"2,301","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":40267.5,"total_display":"40,267.50","total_whole":"40,268","shares_owned_after":24480.0,"shares_owned_after_display":"24,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-05","filed_date":"2018-09-06","scope":"insider"},{"id":6887699,"accession":"0000899243-18-012593","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-012593","line_url":"/filing/0000899243-18-012593#line-2","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":150000.0,"total_display":"150,000.00","total_whole":"150,000","shares_owned_after":9800.0,"shares_owned_after_display":"9,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-09","filed_date":"2018-05-11","scope":"insider"},{"id":6489310,"accession":"0000899243-18-010691","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-010691","line_url":"/filing/0000899243-18-010691#line-1","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8965.0,"shares_display":"8,965","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":116545.0,"total_display":"116,545.00","total_whole":"116,545","shares_owned_after":9800.0,"shares_owned_after_display":"9,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-20","filed_date":"2018-04-24","scope":"insider"},{"id":6177414,"accession":"0000899243-18-008307","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-008307","line_url":"/filing/0000899243-18-008307#line-1","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1035.0,"shares_display":"1,035","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":13455.0,"total_display":"13,455.00","total_whole":"13,455","shares_owned_after":18765.0,"shares_owned_after_display":"18,765","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-19","filed_date":"2018-03-21","scope":"insider"},{"id":2640457,"accession":"0000899243-16-019989","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-16-019989","line_url":"/filing/0000899243-16-019989","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":3.2868788,"price_display":"3.29","price_state":"stated","total_value":16434.394,"total_display":"16,434.39","total_whole":"16,434","shares_owned_after":19800.0,"shares_owned_after_display":"19,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-12","filed_date":"2016-05-16","scope":"insider","n_lines":3},{"id":6525032,"accession":"0001209191-14-012285","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-012285","line_url":"/filing/0001209191-14-012285#line-3","is_derivative":false,"issuer_cik":"0001399529","issuer_name":"Dicerna Pharmaceuticals Inc","issuer_ticker":"DRNA","issuer_name_source":null,"issuer_url":"/issuer/0001399529","owner_cik":"0001598480","owner_name":"Weissman James B","owner_display_name":"Weissman James B","owner_url":"/insider/0001598480","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","total_whole":"15,000","shares_owned_after":13116.0,"shares_owned_after_display":"13,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-29","filed_date":"2014-02-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":35,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":31,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":35},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001399529","name":"Dicerna Pharmaceuticals Inc","url":"/issuer/0001399529","role":"Officer (Chief Operating Officer & EVP)","n_filings":29,"first_seen":"2014-02-20","last_seen":"2021-07-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001598480","retrieved_at":"2026-08-24T19:12:37+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}